This amounts to about 25% of the region’s population at risk, yet only two drugs, nifurtimox and benznidazole - neither ideal - can treat the acute phase; for chronic Chagas Disease there is no treatment at all.
This amounts to about 25% of the region’s population at risk, yet only two drugs, nifurtimox and benznidazole - neither ideal - can treat the acute phase; for chronic Chagas Disease there is no treatment at all.